Kilitch Drugs (India) has formed a joint venture in the Republic of Ethiopia with a local party in that country to set up a pharmaceutical/nutraceutical manufacturing unit. Kilitch Drugs (India) will be a 97 per cent partner in the JV, and the Ethiopian partner would hold the remaining 3 per cent. The company did not disclose any other financial details of the JV. Shares of Kilitch Drugs surged 19.87 per cent at ₹38 on the NSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.